Sector
PharmaceuticalsOpen
₹186.88Prev. Close
₹186.88Turnover(Lac.)
₹403.35Day's High
₹196.22Day's Low
₹180.7252 Week's High
₹202.2952 Week's Low
₹46.7Book Value
₹7.04Face Value
₹10Mkt Cap (₹ Cr.)
641.81P/E
20.09EPS
9.28Divi. Yield
031 Aug 2023
12:00 AM
AGM
Announcement Date: 31 Aug, 2023
20 Oct 2023
12:00 AM
EGM
7 May 2024
12:00 AM
Board Meeting
Agenda : Audited Result
26 Oct 2023
12:00 AM
BookCloser
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 32.71 | 32.67 | 25.02 | 25 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -39.96 | -30.48 | -155.67 | -142.83 |
Net Worth | -7.25 | 2.19 | -130.65 | -117.83 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 392.51 | 367.45 | 371.66 | 433.8 |
yoy growth (%) | 6.82 | -1.13 | -14.32 | 2.49 |
Raw materials | -217.14 | -175.73 | -174.09 | -196.97 |
As % of sales | 55.32 | 47.82 | 46.84 | 45.4 |
Employee costs | -64.14 | -67.47 | -87.32 | -87.77 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | -12.4 | -17.96 | -32.36 | 62.4 |
Depreciation | -9.75 | -9.68 | -10.3 | -10.31 |
Tax paid | -0.2 | -0.2 | 0.37 | -0.38 |
Working capital | -11.56 | -7.53 | -58.84 | -73.01 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 6.82 | -1.13 | -14.32 | 2.49 |
Op profit growth | -23.14 | -134.75 | -464.11 | -42.95 |
EBIT growth | -28.4 | -1,016.65 | -101.66 | 294.25 |
Net profit growth | -119.55 | -301.52 | -151.57 | -981.55 |
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|---|
Gross Sales | 575.65 | 499.65 | 511.19 | 392.52 | 367.45 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 575.65 | 499.65 | 511.19 | 392.52 | 367.45 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 28.55 | 0.91 | 77.88 | 2.4 | 83.78 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,568.65 | 123.31 | 3,76,323.69 | 867.6 | 0.86 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,519.8 | 76.17 | 1,19,994.45 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,485.5 | 32.29 | 1,19,928.54 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,144.45 | 33.51 | 1,15,173.54 | 1,405.2 | 0.26 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,636 | 25.85 | 1,10,759.07 | 1,034.8 | 0.6 | 5,081.8 | 1,458.96 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Independent Director
N K Puri
Vice Chairman & Whole Time Dir
K Chandran
Company Sec. & Compli. Officer
Jitendra J Gandhi
Independent Director
Pallavi Shedge
Independent Director
Pravin Dilip Pawar
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Wanbury Ltd
Summary
Wanbury Ltd (Formerly known Pearl Organics Limited) was incorporated in August, 1988. The Company is engaged in the business of pharmaceutical and related activities, including research.The company has established its first plant in the year 1992 in Tarapur for manufacturing APIs. In 1995, the Company acquired plant of Brij Chemicals Pvt Ltd at Patalganga. In 1996, it entered into a strategic alliance with Wyckoff Chemicals to manufacture its API in US.In 2007-08, the merger of Doctors Organic Chemicals Limited (DOCL) with the Company became effective from 1st April, 2007. Pursuant to the aforesaid Order of the Honble Bl FR 7,85,557 Equity Shares of face value of Rs. 10/- each of the Company were issued to the Equity Shareholders of DOCL on 17th March, 2008. Similarly, the Pharmaceutical Products of India Limited (PPIL) was merged with the Company effective from April 1, 2006. In terms of the said Scheme of Merger, the Company had issued 5,62,618 Equity Shares of face value of Rs. 10/- each to the Equity Shareholders of PPIL on 27 June, 2007, which got listed on Bombay Stock Exchange Limited and National Stock Exchange Limited respectively.The company entered into a strategic association with Bravo Healthcare Ltd and incorporated Ningxia Wanbury Fine Chemicals Co Ltd to source raw materials from China. It opened its office in Zurich,Switzerland for its CRAMS business and incorporated Wanbury Global FZE in Middle East for carrying out its trading activities in the year 2008.Th
Read More
What is the Wanbury Ltd share price today?
The Wanbury Ltd shares price on N/A is Rs.₹195.75 today.
What is the Market Cap of Wanbury Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Wanbury Ltd is ₹640.99 Cr. as of 22 Jul ‘24
What is the PE and PB ratio of Wanbury Ltd?
The PE and PB ratios of Wanbury Ltd is 20.09 and 21.94 as of 22 Jul ‘24
What is the 52 Week High and Low of Wanbury Ltd?
The 52-week high/low is the highest and lowest price at which a Wanbury Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Wanbury Ltd is ₹46.56 and ₹202.35 as of 22 Jul ‘24
What is the CAGR of Wanbury Ltd?
Wanbury Ltd's CAGR for 5 Years at 62.12%, 3 Years at 29.45%, 1 Year at 293.60%, 6 Month at 25.77%, 3 Month at 22.75% and 1 Month at 16.28%.
What is the shareholding pattern of Wanbury Ltd?
The shareholding pattern of Wanbury Ltd is as follows:
Promoters - 39.79 %
Institutions - 0.23 %
Public - 59.98 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
